The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 09, 2023
Filed:
Jan. 04, 2021
Applicant:
Accutar Biotechnology, Brooklyn, NY (US);
Inventors:
Assignee:
ACCUTAR BIOTECHNOLOGY, Brooklyn, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 31/519 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); A61K 31/4995 (2006.01); A61K 31/501 (2006.01); A61K 31/444 (2006.01); A61K 31/551 (2006.01); A61K 31/5386 (2006.01); A61K 31/4985 (2006.01); A61K 31/4439 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/4995 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/5386 (2013.01); A61K 31/551 (2013.01); A61P 35/00 (2018.01);
Abstract
Provided herein are pharmaceutical combinations, compositions, and methods of using a compound with estrogen receptor (ER) degradation activity, such as a compound of formula (I) or a tautomer, stereoisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt, or hydrate thereof, wherein R, Y, R, R, R, p, X, X, and Z are defined herein and a cyclin-dependent kinase (CDK) inhibitor.